Effect of Xiongbing compound on the pharmacokinetics and brain targeting of tetramethylpyrazine

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 11, 2012, Pages 1688-1694

  Wang, Li Sheng ^a   Shi, Zong Feng ^a   Zhang, Ying Feng ^a   Guo, Qi ^a   Huang, Yu Wei ^a   Zhou, Li Ling ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

brain targeting; HPLC microdialysis; pharmacokinetics; tetramethylpyrazine; Xiongbing compound

Indexed keywords

BORNEOL; LIGUSTICUM CHUANXIONG EXTRACT; TETRAMETHYLPYRAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN; COMPARTMENT MODEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MICRODIALYSIS; MICROEMULSION; NONHUMAN; RAT; TARGET ORGAN;

ANIMALS; AREA UNDER CURVE; BORNANES; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; DRUGS, CHINESE HERBAL; EMULSIONS; HALF-LIFE; HERB-DRUG INTERACTIONS; MALE; MICRODIALYSIS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; VASODILATOR AGENTS;

EID: 84867575991     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01546.x     Document Type: Article

References (25)

1. Baldwin K, et al,. Acute ischemic stroke update. Pharmacotherapy 2010; 30: 493-514.
2. Ansara AJ, et al,. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature. Ann Pharmacother 2010; 44: 851-862.
3. Leys D, et al,. Antiplatelet drugs for ischemic stroke prevention. Cerebrovasc Dis 2009; 27: 120-125.
4. Chen C, et al,. Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery. Stroke 2009; 40: 859-863.
5. Jung WS, et al,. Safety and efficacy assessment of chungpyesagan-tang for acute ischemic stroke. Am J Chin Med 2003; 31: 181-190.
6. Rivard AL, et al,. Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. Am J Chin Med 2007; 35: 279-295.
7. Wang C, et al,. Neuroprotective effects of emodin-8-O-beta-D-glucoside in vivo and in vitro. Eur J Pharmacol 2007; 577: 58-63.
8. Zhou L, et al,. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45: 1345-1359.
9. Cai Y, et al,. Observation on curative effect of acute ischemic cerebrovascular disease treated with different dosage of ligustrazine. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000; 20: 747-749.
10. Chen KJ, Chen K,. Ischemic stroke treated with Ligusticum chuanxiong. Chin Med J (Engl) 1992; 105: 870-873.
11. Gao BT,. The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1989; 22: 148-151, 191.
12. Liao SL, et al,. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett 2004; 372: 40-45.
13. Tsai TH, Liang C,. Pharmacokinetics of tetramethylpyrazine in rat blood and brain using microdialysis. Int J Pharm 2001; 216: 61-66.
14. Wan H, et al,. Protective effect of chuanxiongzine-puerarin in a rat model of transient middle cerebral artery occlusion-induced focal cerebral ischemia. Nucl Med Commun 2008; 29: 1113-1122.
15. Zhu XL, et al,. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neurosci Lett 2009; 449: 24-27.
16. Oh KS, et al,. Inhibition of nicotinic receptor-mediated catecholamine secretion by Dryobalanops aromatica in bovine adrenal chromaffin cells. Pharmacol Res 2000; 42: 559-564.
17. Park TJ, et al,. Inhibition of acetylcholine-mediated effects by borneol. Biochem Pharmacol 2003; 65: 83-90.
18. Kim H, et al,. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects. Br J Clin Pharmacol 2010; 70: 126-131.
19. Yan-Yu X, et al,. The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse. Int J Pharm 2007; 337: 74-79.
20. Wang LS, et al,. Preparation and quality control of Xiongbing microemulsion. China Journal of Chinese Materia Medica 2011; 36: 142-146.
21. Guo Q, et al,. Protective effects of Xiongbing microemulsion on cerebral ischemia/reperfusion injury. Tradit Chin Drug Res Clin Pharmacol 2010; 21: 477-480.
22. Paxions G, Watson C,. The Rat Brain in Stereotaxic Coordinates, 1st edn. New York: Academic Science, 1982.
23. Zhang W, Fang XL,. Significant role of poloxamer in drug transport across blood-brain barrier. Yao Xue Xue Bao 2008; 43: 890-897.
24. Sun HS, et al,. Pharmacokinetic Research of Xiongbing Nasal Spray in the Brain. Tradit Chin Drug Res Clin Pharmacol 2003; 14: 177-179.
25. Li C, et al,. In vivo mechanistic studies on the metabolic activation of 2-phenylpropionic acid in rat. J Pharmacol Exp Ther 2003; 305: 250-256.